Background: Neoadjuvant radiochemotherapy has proven superior to adjuvant treatment in reducing the rate of local recurrence without impairing cancer related survival or the incidence of distant ...

Colorectal cancer (CRC) represents a major ... cancer relapse occurs postoperatively. Chemotherapy improves outcome in the neoadjuvant and adjuvant settings. The timing of chemotherapy before ...

Tumour-free ctDNA detection as a decision tool to support organ preservation in node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision, and observation in the phase II NEO trial ...

A "watch and wait" strategy after total neoadjuvant therapy showed similar outcomes and safety to total mesorectal in stage ...

Despite recent advances in therapy, certain subtypes of colorectal cancer, such as those that are microsatellite instability ...

shows that the liquid biopsy tool can aid in decision-making for organ preservation in patients with node-negative rectal cancer undergoing neoadjuvant chemotherapy. According to InvestingPro data ...

In resectable, locally advanced esophageal squamous cell carcinoma, neoadjuvant Tyvyt plus chemoradiotherapy led to an ...

Survival benefits of adjuvant chemotherapy after surgical resection of para-aortic lymph node metastasis from colorectal cancer: A multicenter retrospective study. Fruquintinib plus best supportive ...

Dr Zaheer Mangera discusses the evolution of the neoadjuvant lung cancer pathway and notable changes to the TNM standards.

"Data presented at ASCO GI highlight botensilimab and balstilimab’s potential to redefine colorectal cancer treatment, delivering remarkable outcomes in neoadjuvant MSS CRC," said Dr. Steven O ...